News
CAM2029 reduces liver and cyst volume growth compared to placebo Well tolerated with no new or unexpected safety findingsA follow-up Phase 3 study will be discussed with regulatory authoritiesLUND ...
A Portland dog survived a deadly dose of the sugar substitute xylitol, and local veterinarians are sounding the alarm on the danger of xylitol to dogs.
Camurus (NASDAQ STO: CAMX) today announced topline results from the 12-month, randomized, double-blind, placebo-controlled POSITANO Phase 2b study (NCT05281328), evaluating efficacy and safety of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results